Matthew M. Roden, Ph.D. - Publications

Affiliations: 
2004 Yeshiva University, New York, NY, United States 
Area:
Immunology

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Roden MM, Brims DR, Fedorov AA, DiLorenzo TP, Almo SC, Nathenson SG. Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentation. Molecular Immunology. 43: 1370-8. PMID 16229893 DOI: 10.1016/J.Molimm.2005.08.005  0.43
2002 Ostrov DA, Roden MM, Shi W, Palmieri E, Christianson GJ, Mendoza L, Villaflor G, Tilley D, Shastri N, Grey H, Almo SC, Roopenian D, Nathenson SG. How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination. Journal of Immunology (Baltimore, Md. : 1950). 168: 283-9. PMID 11751972 DOI: 10.4049/Jimmunol.168.1.283  0.423
1998 Kim CJ, Cormier J, Roden M, Gritz L, Mazzara GP, Fetsch P, Hijazi Y, Lee KH, Rosenberg SA, Marincola FM. Use of recombinant poxviruses to stimulate anti-melanoma T cell reactivity Annals of Surgical Oncology. 5: 64-76. PMID 9524710 DOI: 10.1007/Bf02303766  0.335
1997 Kim CJ, Prevette T, Cormier J, Overwijk W, Roden M, Restifo NP, Rosenberg SA, Marincola FM. Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro Journal of Immunotherapy. 20: 276-286. PMID 9220317 DOI: 10.1097/00002371-199707000-00004  0.325
Show low-probability matches.